Sophrosyne Capital’s Axogen AXGN Stock Holding History

Sophrosyne Capital’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-237,266	Closed	-$745K	–	9
2015 Q2	$745K	Sell	237,266 -252,463	-52%	-$815K	5.58%	7
2015 Q1	$1.71M	Hold	489,729	–	–	2.94%	15
2014 Q4	$1.76M	Sell	489,729 -60,878	-11%	-$178K	2.71%	13
2014 Q3	$1.34M	Hold	550,607	–	–	1.59%	22
2014 Q2	$1.53M	Hold	550,607	–	–	1.56%	18
2014 Q1	$1.68M	Sell	550,607 -81,000	-13%	-$323K	1.47%	18
2013 Q4	$2.83M	Sell	631,607 -124,121	-16%	-$504K	2.48%	15
2013 Q3	$3.36M	Buy	+755,728	New	+$2.78M	2.22%	16

Other funds holding AXGN

EWM

Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

FTIOP

Fiduciary Trust International of Pennsylvania Radnor, Pennsylvania $2.14B AUM 3.72% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Sophrosyne Capital's AXGN Position: Q3 2015 in Review

Sophrosyne Capital sold out of Axogen (AXGN) in Q3 2015, closing a stake of 237,266 shares — an estimated $745K sold.

Sophrosyne Capital first reported a position in AXGN in Q3 2013 and held it in 8 quarters. The position peaked at $3.36M in Q3 2013. 38 funds tracked by Wall St. Rank hold AXGN as of Q3 2015.

Sophrosyne Capital reported no remaining Axogen position as of Q3 2015 after selling out during the quarter.
Sophrosyne Capital sold 237,266 Axogen shares in Q3 2015, an estimated $745K.
Sophrosyne Capital first reported a position in Axogen in Q3 2013 and held it in 8 quarters.
Sophrosyne Capital's Axogen position peaked at $3.36M in Q3 2013.
38 funds tracked by Wall St. Rank held Axogen as of Q3 2015.

Based on Sophrosyne Capital's 13F filing for Q3 2015, filed 13 Nov 2015.